News

The outlook for decreasing the maternal mortality rate in the country has recently improved as a result of a recent initiative by the Joint Commission, which has developed 13 new elements of performance (EOPs) to help evaluate hospitals.

Crisis tests a business's culture. It also is a good time to create or strengthen a culture.

The risk of long-term use of oral corticosteroids are well known. This research shows that short "bursts" of one to two weeks also carry some risk of adverse events.

Almost 40% of trials are designed to have fewer than 100 patients.

Drug helps with heavily-treatment experienced (HTE) adults with multidrug-resistant HIV-1 infection.

Researchers cost-impact model calculates the cost to be 15 centers PMPY.

FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.

Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars. 

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.

The veteran healthcare executive says this may be a Netflix vs. Blockbuster moment for hospitals. And health plans may be under pressure to meet the statutory levels for medical spending and recontract with their networks to offer enhanced payments in return for clinical improvement activities.

More than half of approximately 600 consumers (52%) surveyed in mid-March—the time when major metropolitan areas began issuing “shelter-in-place” orders and encouraging “social distancing”—said they had not been given direct guidance from either their payers or providers regarding the novel coronavirus.

Price of the drug to treat hospitalized patients revealed.

Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.

Spotlight report on healthcare discredits the widely held belief that external threats would lead to an increase in data breaches during the COVID-19 pandemic.

"I don't know about you, but in March I was scared; now I'm mostly depressed..."

Data to assess the prevalence and severity of COVID-19 among pregnant U.S. women and determine whether signs and symptoms differ among pregnant and nonpregnant women are limited, according to a report by the CDC.

Company's price is lower than ICER's $50k per-QALY assessment.

An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.

Penn's David Fajgenbaum, M.D., MBA, is branching out from Castleman disease to assemble comprehensive registry of drugs to treat COVID-19.

COVID-19 has applied a type of pressure on the U.S. this year that none of us have experienced in our lifetimes. Like every other segment of healthcare professionals, certified physician assistants have been put to the test during 2020.

The COVID-19 outbreak has tried the souls of people the world over, both personally and professionally, and healthcare executives are no exception. Despite seeing their plans and schedules torn up, executives can meet and master the unrelenting demands of leadership when a typical workday is anything but. Consider these tips from your industry peers to not just survive but also thrive — and to inspire your employees to do the same.

Farzad Mostashari and Ezekiel Emanuel agree: The COVID-19 experience could be what finally weans American healthcare off of its dependence on fee-for-service payment. But they have a slightly different vocabulary and different notions about what might lead to a tipping point.

COVID-19 forced a shift to virtual behavioral health therapy. Some once-skeptical providers, however, are finding telehealth beneficial. Reimbursement and continued relaxation of regulations will determine whether it’s here to stay.

John D'Amore, president and co-founder for Diameter Health, speaks with Managed Healthcare Executive Senior Editor, Peter Wehrwein, about fast healthcare interoperability resources standards , or FHIR, as they apply to insurers. There are new CMS FHIR regulations for Medicare Advantage and Medicaid managed care plans that go into effect in July 2021. Private insurers are expected to follow suit.